Connect Biopharma (CNTB) Stock Forecast & Price Target

$0.98 -0.08 (-7.92%)

(As of 05:26 PM ET)

Connect Biopharma - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy

Based on 1 Analyst Ratings

Sell
0

Hold
0

Buy
1

Based on 1 Wall Street analysts who have issued ratings for Connect Biopharma in the last 12 months, the stock has a consensus rating of "Buy." Out of the 1 analysts, 1 has given a buy rating for CNTB.

Consensus Price Target

$8.00
719.59% Upside

According to the 1 analysts' twelve-month price targets for Connect Biopharma, the average price target is $8.00. The highest price target for CNTB is $8.00, while the lowest price target for CNTB is $8.00. The average price target represents a forecasted upside of 719.59% from the current price of $0.98.

Get the Latest News and Ratings for CNTB and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Connect Biopharma and its competitors.

CNTB Analyst Ratings Over Time

Type	Current Forecast 12/19/23 to 12/18/24	1 Month Ago 11/19/23 to 11/18/24	3 Months Ago 9/20/23 to 9/19/24	1 Year Ago 12/19/22 to 12/19/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	1 Buy rating(s)	1 Buy rating(s)	1 Buy rating(s)	2 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$8.00	$8.00	$8.00	$6.00
Forecasted Upside	719.59% Upside	692.08% Upside	545.47% Upside	597.67% Upside
Consensus Rating	Buy	Buy	Buy	Buy

U.S. Government: “this could save civilization.” (Ad)

Experts indicate that ChatGPT alone consumes up to 17,000 times more electricity than the average U.S. household uses in a single day. And with companies like Google and Microsoft implementing AI into everything we do, that energy consumption is only going to exponentially increase. Thing is, outside of a small group of elite investors, nobody has connected the dots on how this military contractor could be the most important company in the AI boom.

To get all the details, go here now.

CNTB Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CNTB Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Connect Biopharma Stock vs. The Competition

Type	Connect Biopharma	Medical Companies	S&P 500
Consensus Rating Score	3.00	2.81	2.51
Consensus Rating	Buy	Moderate Buy	Moderate Buy
Predicted Upside	719.59% Upside	28,417.88% Upside	15.36% Upside
News Sentiment Rating	Positive News See Recent CNTB News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
9/6/2024	HC Wainwright 2 of 5 stars	E. Bodnar Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$8.00 ➝ $8.00	+601.75%
9/13/2023	Cantor Fitzgerald 3 of 5 stars		Reiterated Rating	Overweight ➝ Overweight	$5.00	+566.57%
4/12/2023	Leerink Partners 1 of 5 stars	T. Smith Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 11:40 PM ET.

CNTB Forecast - Frequently Asked Questions

: According to the research reports of 1 Wall Street equities research analysts, the average twelve-month stock price forecast for Connect Biopharma is $8.00, with a high forecast of $8.00 and a low forecast of $8.00.
: 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Connect Biopharma in the last twelve months. There is currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" CNTB shares.
: According to analysts, Connect Biopharma's stock has a predicted upside of 719.59% based on their 12-month stock forecasts.
: Analysts like Connect Biopharma more than other "medical" companies. The consensus rating for Connect Biopharma is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how CNTB compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

An extra $2 trillion a year for this industry? (Ad)

We're on the cusp of an energy revolution... I'm not talking about lithium batteries, renewable energies, or nuclear energy. This 'silent energy boom' is bigger than anything we've seen before.

Click here for the shocking truth

This page (NASDAQ:CNTB) was last updated on 12/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Connect Biopharma (CNTB) Stock Forecast & Price Target